Latest News, Grants & Research Reports
Read our latest news, blog posts and research updates right here
Developing personalised treatment for children with neuroblastoma
In 2019, we awarded £236,141 to Dr Suzanne Turner at the University of Cambridge, as part our 2019 research grant round.
Here we meet Dr Turner and find out more about her three year research project aimed at improving the effectiveness of ALK inhibitors for children with neuroblastoma.
International Women's Day 2020
International Women's Day (8th March 2020) is a global day celebrating the achievements of women.
Thanks to your support, we fund amazing researchers working to improve treatments for neuroblastoma. Today we celebrate those female scientists who work tirelessly to help more children with neuroblastoma.
Can a keto diet enhance therapy for neuroblastoma?
In 2019, we awarded nearly £5,000 to Prof Robert Falconer and Xiaoxiao Guo at the University of Bradford.
This research grant enabled them to explore the potential for a ketogenic diet to enhance neuroblastoma therapy. Let’s find out more.
Understanding how neuroblastoma develops
With Children’s Cancer and Leukaemia Group (CCLG), we awarded £72,656 to Dr Anestis Tsakiridis at the University of Sheffield.
The team are working to understand how human trunk neural crest cells become cancerous. This research could lead to further investigations to stop neuroblastoma cells from developing.
Dr Tsakiridis shares his motivations, why team work matters and tells us more about his exciting work.
Dr Zoë Walters’ research into combination therapies
In 2019, as part of our Small Grants programme, we awarded £5,000 to Dr Zoë Walters at the University of Southampton.
Dr Walters tells us more about her research into the treatment of neuroblastoma, why she is passionate about cancer research and how she hopes to make a difference to children with neuroblastoma.
Camels, antibodies and cancer cells
We have joined forces with the Bradley Lowery Foundation to provide funding of £153,369 to the Laman group.
The team hope to develop a new approach in targeting the protein N-Myc, a well known cause of some of the worst neuroblastomas. Dr Laman answers our questions about her role, her team and how camels may help get us a step closer to a cure for neuroblastoma.
Developing a new way to study the spread of neuroblastoma
New research published in the journal Cancer Research, with funding from Neuroblastoma UK, Cancer Research UK and Children with Cancer UK has helped create a new mouse model to help study neuroblastoma, a rare and aggressive childhood cancer.
Using 3D printing to study neuroblastoma
We are providing funding of over £116,000 to Dr Olga Piskareva and her team at the Royal College of Surgeons in Ireland (RCSI).
In this project, Dr Piskareva aims to use 3D printing technology to engineer a novel experimental model and study the biology, and subsequent treatment of, neuroblastoma. “Thanks to funding from Neuroblastoma UK and its dedicated supporters...we hope to develop more effective treatments for children with neuroblastoma, with more tolerable side-effects.”
Improving survival for children with rare cancer
Earlier this year, Neuroblastoma UK joined forces with childhood cancer charities Niamh’s Next Step and The Bradley Lowery Foundation to fund more vital research into neuroblastoma.
“...If this project is successful, it would hopefully lead to the subsequent development of a clinical antibody, for trial in children with neuroblastoma…”
NICE approves neuroblastoma drug
Neuroblastoma UK has welcomed today’s announcement by the National Institute for Health and Care Excellence (NICE) that it has approved Dinutuximab beta for funding in the NHS.